Leids Universitair Medisch Centrum (LUMC) clinical trials
Leids Universitair Medisch Centrum (LUMC) is the lead sponsor of 4 current clinical trials in our EU (CTIS) register.
Leids Universitair Medisch Centrum (LUMC) in the EU trials register (CTIS)
4 trialsAuthorised or ongoing trials in the EU Clinical Trials Information System with Leids Universitair Medisch Centrum (LUMC) as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
Evaluation of Interference and Synergy of Anti-Circumsporozoite Antibodies on GA2-induced Immunity
2026-525353-37-00 · Parasitic Diseases
|
Phase 1 | Authorised | Netherlands |
|
SUNCET: Low sodium oxybate Use for Nocturnal Cluster headache: safety, Efficacy and Tolerability of XYWAV - a Phase 2 Randomized, Double-Blind, Placebo-Controlled, bi-center Study
2025-523293-17-00 · Nervous System Diseases
|
Phase 2 | Authorised | Netherlands |
|
Dual-agent fluorescence-guided surgery for colorectal liver metastases
2025-524755-31-00 · Digestive System Diseases
|
Phase 3 | Authorised | Netherlands |
|
SPRAYDYE-Trial - A phase I/II study to assess the efficacy, safety and tolerability of topically applied 6qc-ICG, a cathepsin-activatable fluorescent probe, for real-time intraoperative resection margin assessment in breast conserving surgery
2025-523166-24-00 · CTIS ↗ · Neoplasms
|
Phase 1 | Authorised | Netherlands |
By trial register
| Register | Trials | Recruiting |
|---|---|---|
| EU register (CTIS) | 4 | — |
A trial with sites in more than one country appears in each of those registers.
Questions about Leids Universitair Medisch Centrum (LUMC) trials
How many clinical trials does Leids Universitair Medisch Centrum (LUMC) sponsor?
Leids Universitair Medisch Centrum (LUMC) is the lead sponsor of 4 authorised or ongoing trials in the EU register (CTIS), as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.